Inhibiting glycogen synthesis prevents lafora disease in a mouse model
Bartholomew A. Pederson(Ball State University), Berge A. Minassian(Hospital for Sick Children), Jonathan R. Epp(University of Toronto), Staci A. Weaver(Indiana University – Purdue University Indianapolis), Paul W. Frankland(University of Toronto), Xiaochu Zhao(Institut thématique Génétique, génomique et bioinformatique), Peter J. Roach(Indiana University School of Medicine), Nela Pencea(Hospital for Sick Children), Cameron Ackerley(SickKids Foundation), Julie Turnbull(Institut thématique Génétique, génomique et bioinformatique)
Cited by 111
Related Papers
Presenilin-1, Nicastrin, Amyloid Precursor Protein, and γ-Secretase Activity Are Co-localized in the Lysosomal Membrane
|Journal of Biological Chemistry|2003|308
Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice
|Molecular Psychiatry|2004|275
Posttraining Ablation of Adult-Generated Neurons Degrades Previously Acquired Memories
|Journal of Neuroscience|2011|179
Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease
|Journal of Biological Chemistry|2008|170
Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin
|Journal of Biological Chemistry|2010|141